Mimedx Group Inc (MDXG): Next-Year EPS Estimate 237.50%
As of 2026-06-11, Mimedx Group Inc (MDXG) has a next-year EPS growth estimate of 237.50%.
On 2026-05-17, analyst consensus for MDXG's next-year EPS growth shifted from 916.48% to 237.50% — a negative change of 678.98 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at -117.97%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 237.50%
- EPS growth this year
- -117.97%
- EPS next quarter (est)
- -$0.03
- Last price
- $3.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 237.50% | -117.97% | -$0.03 | $3.69 |
| 2026-06-10 | 237.50% | -117.97% | -$0.03 | $3.64 |
| 2026-06-09 | 237.50% | -117.97% | -$0.03 | $3.71 |
| 2026-06-08 | 237.50% | -117.97% | -$0.03 | $3.70 |
| 2026-06-07 | 237.50% | -117.97% | -$0.03 | $3.74 |
| 2026-06-04 | 237.50% | -117.97% | -$0.03 | $3.78 |
| 2026-06-03 | 237.50% | -117.97% | -$0.03 | $3.61 |
| 2026-06-02 | 237.50% | -117.97% | -$0.03 | $3.57 |
| 2026-06-01 | 237.50% | -117.97% | -$0.03 | $3.58 |
| 2026-05-31 | 237.50% | -117.97% | -$0.03 | $3.68 |
| 2026-05-28 | 237.50% | -117.97% | -$0.03 | $3.67 |
| 2026-05-27 | 237.50% | -117.97% | -$0.03 | $3.61 |
| 2026-05-26 | 237.50% | -117.97% | -$0.03 | $3.67 |
| 2026-05-25 | 237.50% | -117.97% | -$0.03 | $3.62 |
| 2026-05-24 | 237.50% | -117.97% | -$0.03 | $3.62 |
| 2026-05-21 | 237.50% | -117.97% | -$0.03 | $3.61 |
| 2026-05-20 | 237.50% | -117.97% | -$0.03 | $3.79 |
| 2026-05-19 | 237.50% | -117.97% | -$0.03 | $3.64 |
| 2026-05-18 | 237.50% | -117.97% | -$0.03 | $3.59 |
| 2026-05-17 | 237.50% | -117.97% | -$0.03 | $3.56 |
| 2026-05-14 | 916.48% | -96.09% | -$0.02 | $3.55 |
| 2026-05-13 | 924.00% | -96.09% | -$0.02 | $3.55 |
| 2026-05-12 | 924.00% | -96.09% | -$0.02 | $3.54 |
| 2026-05-11 | 924.00% | -96.09% | -$0.02 | $3.56 |
| 2026-05-10 | 924.00% | -96.09% | -$0.02 | $3.60 |
| 2026-05-07 | 924.00% | -96.09% | -$0.02 | $3.69 |
| 2026-05-06 | 924.00% | -96.09% | -$0.02 | $3.66 |
| 2026-05-05 | 924.00% | -96.09% | -$0.02 | $3.64 |
| 2026-05-04 | 924.00% | -96.09% | -$0.02 | $3.61 |
| 2026-05-03 | 924.00% | -96.09% | -$0.02 | $3.68 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Mimedx Group Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Mimedx Group Inc (MDXG) has a next-year EPS growth estimate of 237.50%, based on analyst consensus.
When was the latest EPS estimate revision for MDXG?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 916.48% to 237.50%.
What sector and industry does Mimedx Group Inc belong to?▾
Mimedx Group Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MDXG appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Mimedx Group Inc (MDXG) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports